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Abstract 
Background: Hypoglycaemia is a frequent complication among admitted children, particularly in malaria-endemic 
areas. This study aimed to estimate the occurrence of hypoglycaemia not only upon admission but throughout the 
first 72 h of hospitalization in children admitted with malaria.
Methods: A simple pilot study to continuously monitor glycaemia in children aged 0–10 years, admitted with 
malaria in a rural hospital was conducted in Southern Mozambique by inserting continuous glucose monitors (CGMs) 
in subcutaneous tissue of the abdominal area, producing glycaemia readings every 5 min.
Results: Glucose was continuously monitored during a mean of 48 h, in 74 children. Continuous measurements 
of blood glucose were available for 72/74 children (97.3%). Sixty-five of them were admitted with density-specific 
malaria diagnosis criteria (17 severe, 48 uncomplicated). Five children (7.7%) had hypoglycaemia (<54 mg/dL) on 
admission as detected by routine capillary determination. Analysing the data collected by the CGMs, hypoglycaemia 
episodes (<54 mg/dL) were detected in 10/65 (15.4%) of the children, of which 7 (10.8%) could be classified as severe 
(≤45 mg/dL). No risk factors were independently associated with the presence of at least one episode of hypogly-
caemia (<54 mg/dL) during hospitalization. Only one death occurred among a normoglycaemic child. All episodes of 
hypoglycaemia detected by CGMs were subclinical episodes or not perceived by caregivers or clinical staff.
Conclusions: Hypoglycaemia beyond admission in children with malaria appears to be much more frequent than 
what had been previously described. The clinical relevance of these episodes of hypoglycaemia in the medium or 
long term remains to be determined.
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Background
Hypoglycaemia is a common problem in paediatric emer-
gency admissions in Africa, and is associated with a wide 
variety of disorders and diseases. In descriptive studies 
conducted in different countries of Africa, the preva-
lence of hypoglycaemia on admission ranged between 3.2 
and 7.3% of the paediatric patients [1–6]. The plasmatic 
glycaemia threshold defining hypoglycaemia has been 
established by the World Health Organization (WHO) 
as  <2.5  mmol/L (45  mg/dL) in an adequately-nourished 
child and <3 mmol/L (54 mg/dL) in a severely malnour-
ished child [7], however, an increased risk of death has 
been associated to intermediate levels of low glycaemia 
[8] and the WHO recommends correction when blood 
glucose  <3.0  mmol/L is detected. Most literature on 
childhood hypoglycaemia links the incidence of hypo-
glycaemia to specific conditions such as malaria, diar-
rhoea or malnutrition, and other life-threatening diseases 
including meningitis and sepsis as causes that contribute 
to its occurrence and outcome [1–4, 9, 10]. Hypogly-
caemia can complicate many childhood diseases being a 
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frequent albeit-treatable cause of death. It is also a factor 
of poor prognosis in admitted children [11].
In patients with malaria, decreased levels of glycaemia 
are common and secondary to the consumption of glu-
cose by the Plasmodium parasite, hyperinsulinism caused 
by quinine (whenever used), and lack of adequate sup-
plementation/oral intake in cases of severe malaria, espe-
cially in cerebral malaria [9, 10, 12, 13]. Its impact can be 
easily understood when assessing the mortality risk in 
patients with malaria. Indeed, mortality in severe malaria 
may increase from 8 to 13.4% in patients with normal 
blood glucose levels to 24–61.5% in the hypoglycaemic 
patients [8, 14, 15].
The studies conducted to date in children admit-
ted with malaria performed their occasional glycaemia 
assessments using glucometers that need a finger prick 
each time the glucose level must be assessed, or relied 
on the analysis of venous blood samples. These meth-
ods only allow limited number of glycaemia assessments 
during the day. However the evolution of blood glucose 
is dynamic and hypoglycaemia may occur and be unde-
tected in severely ill patients in the time lapse between 
two assessments, even after presenting normal blood glu-
cose levels on admission.
To improve monitoring of blood glucose, continu-
ous glucose monitors (CGMs), initially developed for a 
more timely control of adult and paediatric patients suf-
fering from type 1 diabetes, [16, 17], have been recently 
introduced in paediatric intensive care, where they are 
showing a high degree of agreement with standard glu-
cometers [18–20].
Using the CGMs during the initial and most criti-
cal days of admission, could allow a better detection of 
hypoglycaemia episodes, and a comprehensive descrip-
tion of the dynamics and evolution of blood glucose. This 
would help establishing some preliminary risk factors for 
hypoglycaemia during the first days of illness, and help to 
detect those patients who could most benefit from addi-
tional supplementation and a more thorough control to 
improve prognosis during hospitalization.
A pilot study was conducted using CGMs to continu-
ously assess blood glycaemia and aimed to determine the 
occurrence of hypoglycaemia episodes detected by these 
devices in children admitted with malaria, trying to iden-
tify risk factors associated with the development of intra-
admission hypoglycaemic episodes.
Methods
Study site and population
This study was conducted in Manhiça, southern Mozam-
bique. Manhiça is a semi-rural, savannah setting with a 
predominantly young population (19.1% are  <5  years of 
age) [21]. Seasonality is marked, including a hot and rainy 
season (November–April), which coincides with the peak 
transmission season for malaria, and a dry and cooler 
season during the rest of the year.
The Manhiça Health Research Center (CISM) is a lead-
ing research centre in Africa with a well-developed clini-
cal laboratory supporting the Manhiça District Hospital 
(MDH). The CISM runs a demographic surveillance sys-
tem linked to a morbidity surveillance platform estab-
lished at the Manhiça district Hospital and five additional 
primary health centres. A detailed description of CISM 
and the study area can be found elsewhere [21].
Study design
This prospective pilot study, conducted at the Manhiça 
District Hospital during a period of 9  months (1st Sep-
tember 2013 to 31st May 2014), recruited paediatric 
patients diagnosed with malaria in order to estimate the 
real occurrence of hypoglycaemia not only upon admis-
sion but also throughout the first 72 h of hospitalization. 
Children aged ≤10 years and fulfilling criteria for admis-
sion because of malaria diagnosis and living in the study 
area, were eligible to be included in the study if guardians 
agreed.
Hospital morbidity surveillance system
Hospital surveillance data are routinely collected for all 
children less than 15  years old visiting the outpatient 
clinics in the study area and those admitted to the MDH. 
Clinical data, including medical history, physical exami-
nation, routine laboratory basic investigations, ICD-10 
based diagnosis, outcome and medication prescribed are 
collected on questionnaires on a round the clock basis 
and reviewed daily by senior medical staff before being 
entered in specific databases. On admission, a finger-
prick blood sample is collected to determine PCV and 
blood glucose concentration. In order to quantify Plas-
modium falciparum parasitaemia, thick and thin blood 
films are prepared, processed and double read in the 
CISM laboratory according to standard procedures [22]. 
Slides are first read using the ‘Crosses system’ [23] to 
guide case management. Blood cultures are systemati-
cally performed for all children under 2 years of age and, 
in older children, in the presence of severe symptoms or 
according to the admitting clinician’s call.
HIV status information is not routinely collected. An 
HIV rapid diagnostic test or other molecular diagnostic 
methods for those  <18  months of age is performed to 
those children with suspected HIV infection.
Definitions
Malaria is defined at MDH as a positive slide regard-
less of parasitaemia. In order to increase sensitivity 
and specificity of malaria case definition, we used an 
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age cut-off for the level of parasitaemia based on previ-
ous malariometric indicators published for the Manhiça 
District [24, 25]. Thus, for children aged 12  months or 
more, a malaria case was defined as a positive blood 
slide with at least 2500 parasites/µL together with the 
documented presence of fever (≥37.5  °C, axillary) 
or a history of fever in the preceding 24  h. For infants 
(<12 months), no minimum parasitaemia was required. 
Severe malaria was defined following the WHO severe 
malaria latest guidelines [26]. Different thresholds were 
used to define blood glucose levels based on local and 
WHO guidelines [7] and the increased risk of mortal-
ity associated to intermediate levels of low glycaemia 
[4, 8, 15]: (1) severe hypoglycaemia was defined as gly-
caemia  <45  mg/dL (2.5  mmol/L) in a well-nourished 
child or  <54  mg/dL (3.0  mmol/L) in a malnourished 
child, detected through the use of the continuous glu-
cose monitoring device and/or a conventional portable 
bedside glucometers [7]. (2) Any hypoglycaemia implied 
glycaemia  <54  mg/dL (3.0  mmol/L) in well-nourished 
children [7]. (3) Normal-low range glycaemia, defined as 
glycaemia  >54 and  <90  mg/dL (3–5  mmol/L). (4) Sub-
clinical hypoglycaemia was defined as any hypoglycae-
mia episode (as defined above) not accompanied with 
apparent clinical symptomatology, as confirmed by the 
patient or described by the observing clinician. Children 
were not continuously under medical observation and 
some episodes categorized as subclinical could be “non-
witnessed” by clinical staff. (5) Hyperglycaemia was 
defined as a glucose value  ≥198  mg/dL (11.0  mmol/L) 
[7]. Fasting was defined according to American Diabe-
tes Association (ADA) criteria [27]. Weight-for-height 
Z-scores (WHZ) were calculated for each child <5 years 
old and body mass index for age for children aged over 
5 years, using the WHO growth chart [28]. The types of 
acute malnutrition were defined as follows: global acute 
malnutrition (<−2 z-score and/or oedema), severe acute 
malnutrition (<−3 z-scores and/or oedema) or non-
existent (Z-score >−1). Dehydration was defined accord-
ing to WHO guidelines [23].
Study procedures
Recruitment occurred during the working hours (07.00 
am–07.00 pm) in the “Short stay admission” ward (Inter-
namento de curta duração, ICD), where trained people 
were working. Recruitment was based on the first read-
ing of the blood slide and all children with presence of 
parasites, fulfilling inclusion criteria when the devices 
were available were asked to participate in the study. A 
standardized study specific questionnaire was completed 
at the moment of recruitment. Demographic, nutritional 
and clinical data such as vital signs and anthropometry 
were also recorded. Medication, food and liquids other 
than water intakes, and events such as vomiting and diar-
rhoea were daily recorded during the time the CGM was 
inserted.
Laboratory procedures
An initial bedside capillary determination of glycae-
mia was performed on admission as routine manage-
ment of admitted patients at MDH. Blood cultures 
were performed as part of the routine microbiological 
surveillance of admitted paediatric patients ongoing in 
MDH. A slide for malaria diagnosis was performed. No 
other samples were routinely obtained. HIV determina-
tion was offered to any study patient suspected of being 
immunocompromized.
Specific procedures for the continuous measurement 
of blood glucose
We aimed to use the CGMs (iPro2, Medtronic  Iberica® 
SA, Madrid, Spain) for continuous glucose monitoring 
for 72 h starting upon admission. Children enrolled were 
connected to the  Medtronic® devices after the signature 
of an informed consent (IC) by the child’s guardian. The 
CGMS is composed by the ENLITE sensor (glucose sen-
sor) and the Mini Link transmitter (wireless transmitter), 
which does not offer real-time information.
The study personnel were trained in the use of the 
devices. Blood glucose levels in real time as well as cali-
bration of CGM data were performed by taking a capil-
lary blood sample (standard capillary assessment) every 
6 h (4 times a day). Correction of glucose levels was per-
formed when necessary following WHO guidelines with 
an intravenous bolus of 5 mL/kg of 10% dextrose which 
has been the standard of care at MDH(7).
Values recorded through the continuous monitoring 
software were downloaded via Care Link™ after sen-
sor removal. Data obtained with the CGMs were com-
pared with those obtained by capillary blood glucometer 
(CBG). We preferred a finger-prick method, as a com-
parison to CBG, rather than the more accurate labora-
tory method because the first is the most used in clinical 
practice at the MDH.
Statistical analyses
Statistical analyses were performed using StataCorp. 
2015. Stata Statistical Software: Release 14. College Sta-
tion, TX: StataCorp LP. Descriptive statistics were pro-
vided for all variables in the dataset, including frequency 
tabulations for binary/categorical variables and mean and 
standard deviation for normal distributed continuous 
variables and median and interquartile range (IQR) for 
non-normal continuous variables.
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Firth logistic regression was used in order to address 
issues of separability, small sample sizes and bias of the 
parameter estimates. Only children fulfilling malaria 
criteria according to our study definition were included 
in the analysis. A multivariate logistic regression with 
penalized likelihood analysis was performed among 
children fulfilling the age and density-specific malaria 
diagnosis criteria to assess risk factors for having hypo-
glycaemia during the admission measured by the CGM, 
including those variables which showed an association 
with having hypoglycaemia in the univariate analysis, 
based on their size of effect (OR <0.5 or >1.5). Statistical 
significance was set at a p value of <0.05 and Confidence 
intervals (CI) at 95% level.
Paired glucose readings from the continuous glucose 
monitor (when available) and the standard capillary 
assessment (from calibrations and hypoglycaemia confir-
mations) were compared using a modified Bland–Altman 
analysis to measure agreement with repeated measures 
and a Clarke error grid analysis (CEG). The CEG identi-
fied five areas with different error in accuracy combined 
with the severity of clinical consequences:
Region A: values within 20% of the reference sensor.
Region B: values outside 20% of the reference sensor, 
but that would not lead to an inappropriate treatment.
Region C: values leading to an unnecessary treatment.
Region D: values indicating a potentially dangerous 
failure to detect hypo- or hyper-glycaemia.
Region E: values that would confuse treatment of hypo-
glycaemia for hyperglycaemia, and vice versa.
These graphs were produced using R [29].
Results
A total of 74 children with a positive blood slide in the 
first reading and admitted because of malaria at MDH 
were enrolled in the study from September 2013 to May 
2014 (study profile in Fig. 1).
Median (interquartile range, IQR) age on admission was 
31.5 (5–84) months. Thirty-three children of 74 were male 
(44.6%) and 22/74 (29.7%) fulfilled the criteria for being 
considered severe malaria cases. Causes of admission of 
children recruited in the study are summarized in Table 1. 
Glycaemia results at admission were available for all chil-
dren and continuous measurements of blood glucose 
were available for 72 of them (97.3%) as the CGMs failed 
to record glycaemia readings in two children. When dou-
ble reading of parasitaemia was available, seven children 
were found not to meet density-specific malaria diagnosis 
criteria. These children were excluded from the analysis, 
which was therefore restricted to 65 children.
The devices were well tolerated in all patients and no 
adverse skin reactions, infections, or bleeding in the 
insertion site occurred during the study period (Fig.  2). 
No patient inadvertently removed the device during the 
study. The average (standard deviation, SD) hospital stay 
was 2.6 days (0.2). One child with cerebral malaria died.
Glucose levels at admission measured by capillary 
assessment
On admission, blood glycaemia was measured by capil-
lary assessment. Five of sixty-five (7.7%) children pre-
sented hypoglycaemia  <54  mg/dL and three of these 
episodes (4.6%) were categorized as severe (<45 mg/dL). 
Hyperglycaemia was detected in 1/65 (1.5%) patients.
Glucose levels measured by CGMs
Analysing the data collected by the CGM, hypoglycae-
mia (<54 mg/dL) was detected in 10 of the 65 children 
(15.4%). Seven of these ten hypoglycaemia episodes 
(70.0%) were categorized as severe (<45  mg/dL). Six of 
seventy-two (8.3%) had recurrent (more than one) hypo-
glycaemia (<54 mg/dL) episodes detected by the CGM. 
All episodes of hypoglycaemia  <54  mg/dL detected by 
CGMs were subclinical or “non-witnessed” episodes 
with no development of further complications. Mean 
(SD) time between CGMs insertion and sensor activa-
tion was 82.1 (9.3) minutes. Hypoglycaemic episodes 
(<54 mg/dL) were nocturne in 5/10 children with hypo-
glycaemia (50.0%) and the mean (SD) duration of fast-
ing preceding the hypoglycaemic episode was 5.5 h (1.2). 
Hyperglycaemia was detected in 11/65 (15.9%) of the 
patients, occurring in 4/10 (36.4%) in the first 2 h after 
food ingestion.
Table  2 compares some key characteristics upon 
admission in children with any level of hypoglycaemia 
with those who remained normoglycaemic throughout 
their entire hospitalization, as determined by CGMs. 
Univariate analysis showed median age was not signifi-
cantly different between the hypoglycaemic (<54 mg/dL) 
and normoglycaemic groups (39, vs 27  months, respec-
tively, OR 1.01 (0.99–1.03), p = 0.514). None of the risk 
factors assessed in the univariate analysis appeared to be 
significantly associated with having more hypoglycaemia 
(any level) during the hospital admission. The majority 
of children (32/47) were fasting during the night. One of 
the ten children (10%) who had a hypoglycaemic episode 
determined by CGMs during hospitalization also had 
presented with hypoglycaemia upon admission. Higher 
axillary temperature was significantly different between 
those with normal glycaemia and those with at least one 
hypoglycaemia episode (<54  mg/dL) in the univariate 
analysis. No difference in duration of hospital stay was 
found. Only one normoglycaemic child died as compared 
to none of the hypoglycaemic children.
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The multivariate analysis showed no risk factors inde-
pendently associated with the presence of at least one 
episode of any level of hypoglycaemia during the admis-
sion (Table  3). Four risk factors showed great effect 
(OR  >2 or  <0.5), but none were significantly associ-
ated with the development of hypoglycaemia during 
hospitalization.
Agreement between continuous measurements of blood 
glucose using continuous glucose monitor and blood 
glucose levels using capillary blood glucometer
We used data from 72 patients where CGM measure-
ments were available to assess agreement between both 
methods of measuring blood glucose. It was possible to 
obtain 474 paired CGM-CBG measurements. Figure  3 
HOSPITAL 
2124 children <10 years of age 
admi
ed at Manhiça's District hospital 
during study period    (Sept. 2013-May 
2014)
1029 (48.4%) children admi
ed with 
malaria 
* 425 living out of study area                                                         
* 13 refusals                                                                                      
* 23 no 	me to ask for inform consent before interven	ons 
(severely ill)         
* 57 children admission due to other condi	ons (not 
because of malaria)                  
* 277 children admied at 	me with no device available 
(all available in use)                                                                     
* 160 children admied out of open hours of  “Short stay 
admission” ward.
Exclusions
74 children recruited 
with malaria based on 
first read of slide.
65 children fulfilling 
malaria criteria aer 
double read of slide.
Fig. 1 Study profile
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shows the Clarke error grid analysis, where 79.0% of 
measurements fell in region A, 19.0% of measurements 
fell in region B, and 2.0% of measurements in region D, 
without any value in region C or E.
Figure 4 illustrates the Bland–Altman agreement plot. 
The 95% limits of agreement (−37.0, 40.0  mg/dL) con-
tained 96% (455/474) of the difference scores. The mean 
difference of the measurements between CGM and CBG 
methods was 1.5 mg/dL.
Discussion
This is the first study conducted in a low-income coun-
try using CGMs in a rural district hospital. Addition-
ally, it is the first study assessing glucose homeostasis 
thorough CGMs in children with malaria. Continuous 
glucose monitoring has been advocated for many years 
to improve glycaemic management in critical care set-
tings [18, 20], among diabetic patients [30, 31] or among 
preterm babies [32]. In the present study, the aim was 
to conduct a descriptive study using these CGMs to 
continuously assess blood glucose, and eventually detect 
hypoglycaemic episodes in children with malaria. The 
prevalence of hypoglycaemia (<54  mg/dL) on admis-
sion in this population was 7.7%, more than twofold 
higher than that found for all-cause admissions in the 
same setting [4] and similar to that found in other stud-
ies in sub-Saharan Africa for malaria inpatients, although 
hypoglycaemia definition was not uniform across the 
studies [1–3, 15, 33–36].
A previous study conducted in the same hospital dem-
onstrated that malaria was a strong predictor of hypo-
glycaemia (OR 1.29, 95% CI 1.09–1.52, p value 0.003) 
[4]. Since the current study population was restricted to 
children admitted with malaria, a higher prevalence of 
hypoglycaemia would have been expected compared to 
the previous study, which included all-cause admitted 
children.
Using CGMs, at least one episode of hypoglycaemia 
(<54 mg/dL) was detected in 10/65 children (15.4%) and 
in 7/65 (10.8%) using  <45  mg/dL threshold, confirm-
ing our pre-defined hypothesis that hypoglycaemia in 
patients with malaria occurs much more frequently than 
previously described. Only a few studies have explored 
blood glucose levels beyond admission and throughout 
hospitalization [15, 36, 37] and using hypoglycaemia 
thresholds of <54 mg/dL [15] or <45 mg/dL [37], showed 
a similar prevalence of hypoglycaemia post-admission 
compared with that found in our study. These studies 
used standard procedures to measure blood glucose lev-
els such as blood capillary determination [15, 37] and/or 
venous samples [15, 36, 37]. However, no previous data 
exist on the occurrence of hypoglycaemia in children 
with malaria measured with such devices. Only one child 
with normal-low glycaemia level was detected on admis-
sion who did not develop later hypoglycaemia (<54 mg/
dL) and survived. This is against to what other authors 
have reported as an increased risk of later hypoglycaemia 
and mortality in children with intermediate low glycae-
mia levels [5, 8, 11]. This difference is likely due to the 
small sample size and different blood glucose level to 
define hypoglycaemia.
CGMs were not useful to measure glycaemia at the 
time of admission, since the sensors started, as expected 
[38], to detect glucose levels more than 1 h after its inser-
tion, a timing which could make hypoglycaemia con-
sequences become irreversible. Only one child among 
those with hypoglycaemia on admission presented sub-
sequently hypoglycaemia episodes determined by CGMs. 
None of the hypoglycaemia episodes were recognised by 
clinical staff or caregivers, and 50% of these hypoglycae-
mia episodes were nocturnal. Reasons for this lack of rec-
ognition may include, among others, lack of clinical staff 
at night, poor awareness of symptoms by caregivers or 
Table 1 Cause of admission of children participants of the 
study
a Two of children admitted with severe anaemia had also cerebral malaria
Cause of admission Uncomplicated malaria 
N = 52, n (%)
Severe malaria 
N = 22, n (%)
Prostration 9 (17.3) NA
Vomiting 7 (13.5) NA
Difficulty to drink 4 (7.7) NA
Hyperparasitaemia (first 
read of blood slide)
32 (61.5) NA
Cerebral malaria NA 13
Severe anaemia NA 8a
Hypoglycaemia (<2.5 
mmol/L)
NA 3
Fig. 2 Continuous glucose monitor inserted in a child participating 
in our study
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Table 2 Risk factors associated to  hypoglycaemia among  patients admitted with  a malaria diagnosis, according to  the 
univariate analysis
Normoglycaemia  
N = 55, n (%)
Hypoglycaemia 
N = 10, n (%)
ORe and 95% CI p  valuee
Socio-demographic characteristics
 Age in months (median, IQR)a 27 (10–65) 39 (32–65) 1.01 (0.99–1.03) 0.514
 Male gender 30 (54.6) 7 (70.0) 1.79 (0.45–7.07) 0.405
 Current breastfeeding 21 (38.2) 2 (20.0) 0.47 (010–2.14) 0.330
History of the current disease
 History of fever 55 (100.0) 10 (100.0) 1.00
 History of cough 16d (33.3) 4 (40.0) 1.36 (0.36–5.21) 0.650
 History of vomit 7d (14.6) 2 (20.0) 1.63 (0.33–8.14) 0.553
 History of diarrhoea 7d (14.6) 1 (10.0) 0.87 (0.13–5.78) 0.889
 Difficulties to breastfeed/anorexia 23 (41.8) 3 (30.0) 0.65 (0.16–2.56) 0.533
 Difficulties to drink 11 (20.0) 2 (20.0) 1.14 (0.24–5.37) 0.870
 Fasting ≥8 h 37 (67.3) 6 (60.0) 0.71 (0.19–2.68) 0.616
 History of seizures 11d (22.9) 1 (10.0) 0.52 (0.08–3.26) 0.481
Anthropometrics
 Weight in  kgb 27.1 (2.2) 22.6 (4.8) 1.04 (0.92–1.18) 0.497
 Global acute  malnutritionc 3 (5.5) 1 (10.0) 1.93 (0.18–21.13) 0.585
 Severe acute  malnutritionc 1 (1.8) 1 (10.0) 6.00 (0.32–111.87) 0.172
Symptoms and signs on admission
 Axillary temp. (°C)b 38.7d (0.2) 37.7 (0.5) 0.59 (0.35–0.99) 0.046
 Respiratory  rateb 36.0d (1.2) 30.9 (1.9) 0.92 (0.82–1.02) 0.111
 BCS at  admissionb 4.3 (0.2) 3.9 (0.6) 0.83 (0.56–1.23) 0.358
 Respiratory distress 5d (10.4) 0 (0.0) 0.38 (0.02–7.36) 0.520
 Dehydration 3d (6.3) 1 (10.0) 2.05 (0.26–15.73) 0.489
 Pallor 13d (27.1) 5 (50.0) 2.63 (0.69–10.02) 0.157
 Jaundice 1d (2.1) 1 (10.0) 5.00 (0.47–53.38) 0.183
 Oedema 0d (0.0) 1 (10.0) 15.32 (0.58–405.11) 0.102
 Prostration 11 (20.0) 3 (30.0) 1.81 (0.42–7.51) 0.416
 Unconscious (BCS <5) 11 (20.0) 3 (30.0) 1.81 (0.42–7.51) 0.416
 Deep coma (BCS <2) 10 (18.2) 3 (30.0) 2.02 (0.48–8.50) 0.336
Investigation
 Malaria diagnosis 55 (100.0) 10 (100.0) 1.00
 HIV infection 2 (3.8) 1 (10.0) 3.25 (0.38–27.63) 0.280
 Severe anaemia 5d (10.4) 0 (0.0) 0.44 (0.02–8.56) 0.584
 Positive blood culture 1 (1.8) 1 (10.0) 5.74 (0.54–61.11) 0.148
 Hypoglycaemia at admission (<3.0 mmol/L) 4 (7.3) 1 (10.0) 1.81 (0.25–13.00) 0.557
 Hypoglycaemia at admission (<2.5 mmol/L) 2 (3.6) 1 (10.0) 3.38 (0.40–28.68) 0.264
 Normal-low range glycaemia (3–5 mmol/L) 10 (18.2) 1 (10.0) 0.50 (0.06–4.51) 0.529
 Hyperglycaemia at admission (≥11.0 mmol/L) 1 (1.8) 0 (0.0) 1.73 (0.07–45.43) 0.742
 Glycaemia at admission (mmol/L)b 6.3 (0.3) 5.8 (0.6) 0.91 (0.66–1.24) 0.542
 Time up to sensor activation (minutes)b 82.6 (20.3) 79.3 (32.9) 1.00 (0.99–1.01) 0.857
 Hyperparasitaemia (>100,000 parasites/µL) 27 (49.1) 2 (20.0) 0.30 (0.07–1.370) 0.122
Treatment
 Intravenous quinine 1 (1.8) 0 (0.0) 1.73 (0.07–45.43) 0.742
 Intravenous artesunate 51 (92.7) 10 (100.0) 1.84 (0.09–36.71) 0.691
 Blood transfusion 3d (6.3) 1 (10.0) 0.72 (−1.32–2.76) 0.489
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family members, or more simply than those episodes did 
not associate any clinical symptomatology. Alternatively, 
it could also be that certain severe conditions, which may 
last for many hours, including cerebral malaria, may asso-
ciate clinical but difficult to detect hypoglycaemic epi-
sodes in the context of an already altered clinical status. 
Previous studies using the CGMs have confirmed over-
night unrecognized hypoglycaemia is common among 
children with type 1 diabetes [39] but very little is known 
on the impact of recognized and unrecognized hypogly-
caemia in non-diabetic children. On the other hand, fast-
ing is considered a risk factor because it leads to glycogen 
depletion, which can result in decreased glucose produc-
tion and hypoglycaemia [40]. However, using the ADA 
criteria to measure fasting in our study, no association 
between lack of caloric intake for ≥8 h and the develop-
ment of hypoglycaemia could be found. In a study con-
ducted in Suriname, Zijlmans et al. [40] studied glucose 
kinetics in children with P. falciparum malaria during a 
16-h period of controlled fasting. During the following 
8  h after controlled fasting, plasma glucose concentra-
tions decreased and no episodes of hypoglycaemia were 
described. In the same study, a linear regression analysis 
using a mixed linear model was performed and showed 
children with non-severe malaria would develop hypo-
glycaemia after 26  h of controlled fasting and the chil-
dren with severe malaria would develop hypoglycemia 
after 33 h of controlled fasting (p 0.036) [40]. It is likely 
that fasting in this study was too short to find any impact 
on glucose levels in our patients.
Surprisingly, higher axillary temperature was more 
common among those children whose glycaemia 
remained normal in the univariate analysis. This finding 
needs to be interpreted with caution, as no adjustment 
for multiplicity of testing has been performed. No risk 
factors independently associated with having at least one 
episode of any level of hypoglycaemia were found in the 
multivariate analysis. Caution is however needed when 
interpreting these results, since sample size was small 
and likely insufficient to detect significant differences 
among both glycaemia groups.
Only one child died in this cohort. It has been dem-
onstrated that malaria is a risk factor to develop hypo-
glycaemia but it is not a predictor of death because of 
hypoglycaemia [4]. A previous study conducted in the 
same hospital showed that malaria was not a risk factor 
Value in italic is statistically significant
BCS Blantyre coma score
a Age is presented as median (IQR)
b Variables presented as mean (standard deviation)
c Acute malnutrition calculated using weight-for-Height Z score (up to 5 years) or body mass index (>5 years)
d These variables contain missing data for 7 patients
e OR and p value derived from Firth logistic regression
Table 2 continued
Normoglycaemia  
N = 55, n (%)
Hypoglycaemia 
N = 10, n (%)
ORe and 95% CI p  valuee
Outcome
 Length of admission in  daysb 2.5 (0.2) 3.0 (0.6) 1.27 (0.84–1.94) 0.259
 Severe malaria 14 (25.5) 3 (30.0) 1.33 (0.33–5.43) 0.686
 Died 1 (1.8) 0 (0.0) 1.73 (0.07–45.43) 0.742
Table 3 Multivariable analysis of risk factors associated with having at  least one episode of hypoglycaemia during the 
admission
WHZ weight-for-height Z score
a These variables contain missing data for 7 patients
b OR and p value derived from Firth logistic regression
Risk factors Hypoglycaemia  
N = 10, n (%)
Adjusted OR 95% CI p  valueb
Oedemaa 1 (10.0) 20.08 0.74 547.08 0.075
Dehydrationa 1 (10.0) 2.87 0.36 23.02 0.321
Several acute malnutrition (WHZ <−3DS) 1 (10.0) 6.69 0.60 74.41 0.122
Blood culture positivity 1 (10.0) 6.69 0.60 74.41 0.123
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associated to mortality in children with hypoglycaemia 
on admission [4]. However, these findings are restricted 
to blood glucose levels on admission and there are no 
data about newly incident or recurrent hypoglycaemia 
episodes during their continued hospitalization.
The CEG and modified Bland–Altman analyses for all 
glucose levels demonstrated that the CGM provides simi-
lar readings to the CBG. Indeed, 98% of all readings in 
the CEG were included in the safe A or B regions and 
there was no evidence of an increase of the measure-
ments into zones (C, D, E), that would lead to inadequate 
management of hyper- or hypo-glycaemia, as has been 
previously reported in a study conducted in preterm 
newborns [32]. The Bland–Altman analysis showed that 
the 95% limits of agreement contained 96% (455/474) of 
the difference scores. Previous studies conducted in other 
populations have shown that CGMs slightly under-reads 
glucose levels as compared to CBG [32, 41]. This fact 
may be explained on account of the differences among 
studied populations (patients with diabetes or newborns 
versus children with malaria) and/or the use of different 
glucometers.
The CEG was initially used to test the accuracy of 
blood glucose measurement in adults or children with 
diabetes [42]. Two previous studies performed in pre-
term babies [32, 43] utilized the CEG to compare glucose 
Fig. 3 Clarke error grid analysis comparing measures of continuous glucose monitors vs capillary blood glucometer measures. The figure is divided 
in the following 5 regions: Region A values within 20% of the reference sensor; Region B values outside 20% of the reference sensor, but that would 
not lead to an inappropriate treatment, Region C values leading to an unnecessary treatment; Region D values indicating a potentially dangerous 
failure to detect hypo- or hyper-glycaemia; Region E values that would confuse treatment of hypoglycaemia for hyperglycaemia, and vice versa. 
CGM glucose levels measured by continuous glucose monitors, CBG capillary glucose levels measured by a glucometer
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values obtained from a  Medtronic® device with values 
obtained from different blood glucose tests and found 
great correlation between the two methods. However, 
the interpretation of results in a different population and 
with different interventional glucose levels needs to be 
cautious [43].
This study has several limitations. First, the study 
lacked sufficient statistical power to detect significant 
associations between hypoglycaemia and its determi-
nants, given the small sample size. Second, as the number 
of devices was limited, recruitment could not be per-
formed continuously, jeopardizing the representative-
ness of these results. Third, the CGM system has proven 
adequate and robust for hyperglycaemia determination 
[44], but its accuracy may be limited for paired glucose 
recordings during hypoglycaemia [45]. Sensors used in 
this cohort had a minimum threshold of 2.2 mmol/L and 
lower glucose levels were detected, albeit with no meas-
urable values. Finally, and as noted above, the sensor 
may overestimate hypoglycaemia slightly. However, these 
results confirm a good correlation between CGMs and 
capillary assessment.
Conclusions
Although the use of CGM appears insufficiently cost-
effective in resource-constrained settings, these data sug-
gest that the CGM is a clinically accurate instrument to 
evaluate blood glucose levels in children with malaria. 
Moreover, these data suggest that hypoglycaemic events 
detected by conventional glucometers may be only the 
Fig. 4 Bland–Altman plot of the difference between glucose levels measured by continuous glucose monitors (CGM) against those measured by 
capillar determination using a glucometer (CBG). The within-subject variance is estimated by a random effects model. The 95% limits of agreement 
(−37.0, 40.0 mg/dL) contained 95% of the difference scores
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tip of the iceberg of the real burden of hypoglycaemia in 
children admitted with P. falciparum malaria, because 
many more hypoglycaemia episodes seem to occur, in 
spite of their poor clinical translation. A higher sample 
size would be needed to help establishing some prelimi-
nary risk factors for hypoglycaemia during the first days 
of illness, and help detecting those patients who could 
most benefit from additional supplementation and a 
more thorough control to improve prognosis during 
hospitalization.
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